E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/21/2006 in the Prospect News Biotech Daily.

Boston Scientific ups coupon on senior notes due 2015, 2035 by 75 bps

By Angela McDaniels

Seattle, April 21 - Boston Scientific Corp. said it increased the interest rate payable on its $400 million senior notes due 2015 to 6¼% from 5½% and the interest rate payable on its $350 million senior notes due 2035 to 7% from 6¼%.

The interest rate increase will accrue from Nov. 17, 2005.

Boston Scientific adjusted the interest rates due to the closing of its acquisition of Guidant Corp., according to a company news release.

The Natick, Mass., medical device company noted that subsequent upgrades to its long-term senior unsecured debt credit ratings may result in a decrease in the notes' interest rates but in no event will the rate on the notes due 2015 fall below 5½% or the rate on the notes due 2035 fall below 6¼%.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.